EMEA (EUROPE, MIDDLE EAST AND AFRICA) ANTIVENOM MARKET 2017 FORECAST TO 2022

Feb 2018 118

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Scope of the Report:
This report focuses on the Antivenom in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- CSL Behring
- Merck & Co., Inc.
- BTG Plc
- Pfizer
- Haffkine Bio-Pharmaceutical Corporation
- Rare Disease Therapeutics
- Flynn Pharma
- Vins Bioproducts
- Bharat Serums and Vaccines
- Serum Biotech

Market Segment by Regions, regional analysis covers
- Europe (Germany, France, UK, Russia, Italy and Turkey)
- Middle East (Saudi Arabia, Israel, UAE and Iran)
- Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers
- Polyvalent antivenom
- Monovalent antivenom

Market Segment by Applications, can be divided into
- Retail Pharmacies
- Hospitals
- Others

There are 13 Chapters to deeply display the EMEA Antivenom market.

Chapter 1, to describe Antivenom Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Antivenom, with sales, revenue, and price of Antivenom, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Antivenom, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Antivenom market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Antivenom research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Table of Contents

Related reports :

(Oct 18)

The primary growth drivers for the IoT in healthcare market include demand for reduced cost of patient care, improved healthcare outcomes, a...

(Oct 18)

ADME-toxicology testing is the evaluation of the metabolism of a drug molecule and its toxicity in an organism. ADME describes the pharmacol...

(Oct 18)

An immunoassay is a biochemical test that measures the presence or concentration of a macromolecule or a small molecule in a solution throug...

(Oct 18)

Scope of the Report: This report focuses on the Advanced Visualization in global market, especially in North ...

(Oct 18)

Home healthcare refers to home-based healthcare services provided to users at the convenience of their homes. Scope of the Re...

(Oct 18)

A Humanized mouse model is a mouse carrying functioning human genes, cells, tissues, and/or organs. Humanized mice are commonly used as smal...

EMEA (EUROPE, MIDDLE EAST AND AFRICA) ANTIVENOM MARKET 2017 FORECAST TO 2022


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Healthcare market as per your needs. Get the best of Healthcare research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy